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The objectiveofthisprojectisto generate a libraryof monoclonal antibodies (MAbs)
directedagainstsurfacemolecules of tumor and transformed cellsgrown as
multicellspheroids (MCS). These MCS are highlyorganized,3-dimensional
multicellularstructureswhich exhibitmany characteristicsof Jn v/vo organized
tissuesnot found in conventional monolayer or suspension culture.Therefore
MCS make better Jn vitromodel systems to study the interactionsof mammalian
cells,and provide a functionalassay forsurfaceadhesion molecules.
This projectalso involves investigationsof cell-cellinteractionsin a gravity-based
environment. Itwillprovide a base of scientificinformation necessary to expand
the focus of the projectinfutureyears to microgravityand hypergravity-based
environments. This project also has the potentialto yieldimportant materials(e.g.,
cellularproducts) which may prove usefulin the diagnosis and/or treatment of
certainhuman diseases. Moreover, thisprojectsupports the trainingof both
undergraduate and graduate students;thus,itwillassistin developing a pool of
futurescientistswith research experience in an area (gravitationalbiology)of
interestto NASA.
Researr.h Progress Summary
The aims forthisreportingperiod were: (1)to continue to expand our MAb library;
(2)to continue to characterizethe binding pattern and binding intensityof selected
MAbs on panels of human and rodent celllines;and (3)to initiatefunctional
biologicalassays to determine whether MAbs can modulate the cell-cellinteractions
(i.e.,aggregation,compaction) of normal, tumor, or transformed cells.
Additional fusionsresultingin a varietyof MAbs directedagainsta human
neuroblastoma celllinewere performed and hybridomas are currentlybeing cloned.
In addition,three new MAbs directedagainstWI38SV40 fibroblastswere cloned
(WSJ-7 through WSJ-9). These MAbs exhibitstrong binding to human cellsand
slightbinding to rodent cells.The binding patternsof these MAbs are currently
being analyzed furtherby flow cytometry.
MAbs identifiedinthe lastreport were characterizedby immunofluorescence
microscopy and flow cytometry on panels ofhuman and rodent cells.AllMAbs
(WSJ-2 through wsJ-6) directed againstWI38SV40 cellsexhibitedstrong binding to
transformed fibroblstsand slightbinding to normal (diploid)fibroblasts.Further,
MAbs which exhibitinga "cellsurface"binding pattern exhibitedmuch stronger
binding to HeLa (human cervicalcarcinoma) cells.Itisalsointerestingto note that
two MAbs alsoexhibitedslightbinding to CHO 77256 (Chinese Hamster Ovary) cells
but not to other rodent cells.SixMAbs directedagainstB14150 wildtype and 2DI_FI
mutant hamster cellsreported previouslywere characterizedfurtherby
immunofluorescence and flow cytometry on panels of human and rodent cells.
Five MAbs reacted specificallywith rodent cellswhile one MAb (BSGI.1)reacted
with both human and rodent cells
Preliminary aggregation and compaction functional studies were carried out on 96-
well tissuecultureplatescoated with 0.75% agarose solutionand seeded with 103 to
104 cells/well.Fab fragments of one MAb, MTS 1.2,developed againstMTS of
WI38SV40 lung fibroblasts,but not whole antibody,appeared to block cell
aggregation.The assay willbe repeated with appropriate controlsto confirm these
results.A sample of bovine serum albumin (orother appropriate protein)willbe
run through the Fab fragment procedure to ensure thatthe resultsare not due to
non-specificcytotoxiceffects.Additionally,a MAb directedagainsta non-W138SV40
surface antigenwillbe used to exclude the possibilitythatthe blocking of
aggregation isdue to high antibody concentration.
The functionalbiologicalassay was also applied to recent fusions.Supernatants
from wellsof 96-wellplatescontaininghybridomas were testedto see ifthe
supernatants modulated cellaggregation and /or compaction. This willbe a useful
assay to screen allhybridoma supematants as opposed to only screeningselected
MAbs. Firstscreenings of two recent fusionsresultedinthe identificationof
number of supernatants which appeared to block aggregation. These screeningsare
currentlybeing repeated to confirm the preliminaryresults.Various other aspects
of the functionalassays,such as utilizinga shaker platform to ensure uniform
distributionof cellsin the wellsduring incubation,and searching fora commercial
antibody which can be used as a positivecontrolforthe assays are alsobeing
pursued.
This projectalso supported the trainingof two underrepresented minority students
(one graduate and one undergraduate) during the reportingperiod. Both students
made significantprogress intheirresearch training.Moreover, each student
submitted an abstractand presented a paper at a nationalscientificmeeting. One
student (Cynthia Cantu) completed requirements forthe MS. degree in biology and
was accepted to the Universityof Texas Medical School at Houston. She willstartin
the fall.
Future Plans
The specificaims forthe next six-month period are:(I)to continue the cloning,
expansion, characterizationof MAbs; and (2)to continue functionalassays and
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